Risk of neural tube defects higher for babies of women on HIV therapy with dolutegravir

www.sciencedaily.com

Children born to women on HIV therapy containing the drug dolutegravir since conception have a slightly higher risk of neural tube defects, compared to children born to women on regimens of other antiretroviral drugs.

  • 0 Likes

  • 0 Comments